- Home
- SRDX vs CHPT Comparison
SRDX vs CHPT Comparison
Compare SRDX & CHPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRDX
- CHPT
- Stock Information
- Founded
- SRDX 1979
- CHPT 2007
- Country
- SRDX United States
- CHPT United States
- Employees
- SRDX N/A
- CHPT N/A
- Industry
- SRDX Medical/Dental Instruments
- CHPT Industrial Specialties
- Sector
- SRDX Health Care
- CHPT Consumer Discretionary
- Exchange
- SRDX Nasdaq
- CHPT Nasdaq
- Market Cap
- SRDX 562.6M
- CHPT 487.7M
- IPO Year
- SRDX 1998
- CHPT N/A
- Fundamental
- Price
- SRDX $38.61
- CHPT $1.13
- Analyst Decision
- SRDX Hold
- CHPT Hold
- Analyst Count
- SRDX 4
- CHPT 16
- Target Price
- SRDX $43.00
- CHPT $2.47
- AVG Volume (30 Days)
- SRDX 219.6K
- CHPT 12.9M
- Earning Date
- SRDX 11-06-2024
- CHPT 12-04-2024
- Dividend Yield
- SRDX N/A
- CHPT N/A
- EPS Growth
- SRDX N/A
- CHPT N/A
- EPS
- SRDX N/A
- CHPT N/A
- Revenue
- SRDX $126,078,000.00
- CHPT $441,698,000.00
- Revenue This Year
- SRDX $13.75
- CHPT N/A
- Revenue Next Year
- SRDX $13.67
- CHPT $23.54
- P/E Ratio
- SRDX N/A
- CHPT N/A
- Revenue Growth
- SRDX N/A
- CHPT N/A
- 52 Week Low
- SRDX $25.17
- CHPT $1.08
- 52 Week High
- SRDX $42.44
- CHPT $3.13
- Technical
- Relative Strength Index (RSI)
- SRDX 50.28
- CHPT 39.75
- Support Level
- SRDX $37.86
- CHPT $1.08
- Resistance Level
- SRDX $38.93
- CHPT $1.40
- Average True Range (ATR)
- SRDX 0.40
- CHPT 0.08
- MACD
- SRDX 0.08
- CHPT -0.01
- Stochastic Oscillator
- SRDX 62.29
- CHPT 14.06
About SRDX Surmodics Inc.
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.
About CHPT ChargePoint Holdings Inc.
ChargePoint designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.